EMERGE: A multi-centre, non-randomised, single-arm phase II study investigating domatinostat plus avelumab in patients with previously treated advanced mismatch repair-proficient oesophagogastric and colorectal adenocarcinoma
Authors
Slater, S.Cartwright, E.
Saffery, C.
Tran, A.
Smith, G.
Bacason, M.
Zhitkov, O.
Rana, I.
Johnston, E.
Sanna, I.
Aresu, M.
Kohoutova, D.
Terlizzo, M.
Turkes, F.
Smyth, E.
Mansoor, Was
Fribbens, C.
Rao, S.
Watkins, D.
Starling, N.
Chau, I.
Cunningham, D.
Affiliation
The Royal Marsden National Health Service Foundation Trust, London,Issue Date
2022